Data protection Impressum

Medical Devices

Researchers from the Francis Crick Institute and Bern-based AlveoliX have developed the first human lung-on-chip model built entirely from genetically identical cells, opening new perspectives for personalised respiratory disease research.

AlveoliX contributes to first lung-on-chip model using genetically identical human cells

19 January 2026

LEM Surgical presented its Dynamis robotic platform at CES 2026, highlighting its clinical deployment in the U.S. and outlining a new development roadmap integrating NVIDIA’s physical AI technologies.

LEM Surgical showcases its Dynamis robotic system and AI roadmap at CES 2026

19 January 2026

DigeHealth has raised CHF 1.25 million to accelerate the development of a wearable device that continuously monitors gastrointestinal activity using acoustics and artificial intelligence.

DigeHealth raises CHF 1.25 million to advance continuous gastrointestinal monitoring

15 December 2025

Seven medtech start-ups have been selected for the inaugural sitem-insel Innovation Voucher program, further strengthening the canton of Bern’s growing position as a hub for translational medicine and applied life sciences innovation.

sitem-insel launches Innovation Voucher to support emerging medtech companies

10 December 2025

Top Stories Western Switzerland

Top Stories from Western Switzerland (November 2025)

26 November 2025

LEM Surgical has completed its first U.S. clinical procedures using the Dynamis Robotic Surgical System.

Bern’s LEM Surgical completes first U.S. clinical procedures with its Dynamis robotic system

19 November 2025

Renens-based medtech start-up Autonomyo has secured EUR 1.4 million from public and private investors to accelerate the development of its home rehabilitation technologies.

Autonomyo launches crowdfunding to scale home-based robotic rehabilitation

17 November 2025

Top Stories Western Switzerland

Top Stories from Western Switzerland (October 2025)

29 October 2025

Neurotechnology company ONWARD Medical extends its cash runway through 2026 and prepares to expand commercialization and clinical development of its ARC Therapy systems.

ONWARD Medical raises over EUR 50 million to advance spinal cord therapies

27 October 2025

Vaud-based FemTech company Aspivix begins commercial rollout in Southern California and New York following strong clinical validation and growing U.S. demand.

Aspivix launches its breakthrough Carevix device in the United States

21 October 2025

1 2 3 4 5 … 14